Biological Sampling Clause Samples

Biological Sampling. Underwater biological sampling of the marine hull fouling on the Obsolete Vessel is not required and shall not be performed by the Buyer unless authorized by the Contracting Officer in writing. If MARAD determines there is a requirement for conducting biological sampling after the award of the sales contract for the recycling of the vessel the cost for the performance of the sampling activity will be contracted separately by the Contracting Officer.
View SourceView Similar (6)
Biological Sampling i. Check for presence of tags.
View Source
Biological Sampling. For each subject, sampling sessions included whole blood collection, passive saliva and exhaled breath condensate collection [41]. Briefly, venous blood was collected in 3mL, ethylenediaminetetraacetic acid-treated (EDTA) tubes (BD Vacutainer) from either the left or right median cubital vein and centrifuged immediately for plasma retrieval. Saliva was collected passively into sterile 15mL conical centrifuge tubes (Falcon) held against the lips. Rtubes (Respiratory Research) were used to collect roughly ~2mL of exhaled breath condensate. Biological samples from each matrix was aliquoted into microcentrifuge tubes and stored at -80⁰C within 20 minutes of collection. Metabolomic analyses were conducted within four months of collection. Metabolomics and Data Processing. Analytical chemistry was performed following procedures developed by ▇▇▇▇▇▇ et al. (2013). For each sample, 65µL were diluted into 130µL of acetonitrile spiked with isotopic standards. After a 30-minute equilibration and protein precipitation, triplicate 10µL aliquots were placed into autoinjector vials and run across two batches through a C18 reverse phase liquid chromatography coupled with high resolution mass spectrometry (HR-MS) on a QExactive Orbitrap (ThermoFisher) [43]. The analytical platform
View Source

Related to Biological Sampling

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Field The term “